Direxion Daily S&P Biotech Bear 3x Shares (LABD) Holdings $6.73 -0.03 (-0.44%) Closing price 04:10 PM EasternExtended Trading$6.72 -0.01 (-0.15%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipShort InterestBuy This Stock Top 11 LABD HoldingsRankCompanyCurrent PriceWeightShares Held1Dreyfus Govt Cash Man InsN/A54.74%21,768,1842Goldman Sachs Sterling FixInc Port IncN/A32.55%12,945,4153Goldman Sachs Fin Gov 465 InstitutN/A24.06%9,567,2994Dreyfus Trsry Securities Cash MgmtN/A16.10%6,401,5045CashN/A11.39%4,529,2896Ubs CollateralN/A-0.18%70,0007Jpm CollateralN/A-3.72%1,480,0008Baml CollateralN/A-5.73%2,280,0009Citi CollateralN/A-6.48%2,575,00110S&P Biotechnology Select Industry Index SwapN/A-11.09%23,45811Goldman CollateralN/A-11.64%4,630,000 Coupon Exposure4-6100.5% Related Companies and Tools Related Companies Simplify Propel Opportunities ETF Portfolio Companies ProShares Ultra Health Care Portfolio Companies SPDR S&P Health Care Services ETF Portfolio Companies F/m Emerald Life Sciences Innovation ETF Portfolio Companies ALPS Medical Breakthroughs ETF Portfolio Companies ProShares Ultra Nasdaq Biotechnology Portfolio Companies Global X HealthTech ETF Portfolio Companies Invesco Dorsey Wright Healthcare Momentum ETF Portfolio Companies Invesco Nasdaq Biotechnology ETF Portfolio Companies Virtus LifeSci Biotech Products ETF Portfolio Companies This page (NYSEARCA:LABD) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bear 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bear 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
